Chinese omicron-specific mRNA COVID vaccine candidate to be trialed in UAE
China’s Suzhou Abogen Biosciences Co. said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the omicron variant has obtained clinical trial approval in the United Arab Emirates.
With Friday’s…
Read More...
Read More...